1. Deng S, Xu Y, An G, et al. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases. Clin Lymphoma Myeloma Leuk. 2015; 15:286–291. PMID:
25640025.
Article
2. Swerdlow SH, Campo E, Harris NL, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press;2008.
3. Invernizzi R, Pecci A. A case of phagocytic multiple myeloma. Haematologica. 2000; 85:318. PMID:
10702823.
4. Kanoh T, Saigo K. Phagocytic myeloma cells in asymptomatic multiple myeloma. Tohoku J Exp Med. 1987; 153:207–210. PMID:
3433276.
Article
5. Kucukkaya RD, Hacihanefioglu A, Yenerel MN, et al. CD15-expressing phagocytic plasma cells in a patient with multiple myeloma. Blood. 2001; 97:581–583. PMID:
11202432.
Article
6. Ludwig H, Pavelka M. Phagocytic plasma cells in a patient with multiple myeloma. Blood. 1980; 56:173–176. PMID:
7397375.
Article
7. Ramos J, Lorsbach R. Hemophagocytosis by neoplastic plasma cells in multiple myeloma. Blood. 2014; 123:1634. PMID:
24761451.
Article
8. Savage DG, Zipin D, Bhagat G, Alobeid B. Hemophagocytic, non-secretory multiple myeloma. Leuk Lymphoma. 2004; 45:1061–1064. PMID:
15291368.
Article
9. Fernández de, Kyle RA, Durie BG, et al. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia. 2013; 27:780–791. PMID:
23288300.
Article
10. Jurczyszyn A, Olszewska-Szopa M, Hungria V, et al. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Leuk Lymphoma. 2016; 57:2071–2076. PMID:
26726867.
Article
11. Requena L, Kutzner H, Palmedo G, et al. Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases. Arch Dermatol. 2003; 139:475–486. PMID:
12707095.